Recent Articles

February 3, 2016 10:43 am
Ryan Bushey, Associate Editor
Liver disease and HIV therapies are cited as the leading treatments. Read more...
February 3, 2016 8:55 am
Rosanne M. Crooke, Ph.D., Ionis Pharmaceuticals
In recent years research has presented important new findings regarding the mechanism of action of familial chylomicronemia syndrome (FCS), a rare genetic disease that affects production or functionality of lipoprotein lipase (LPL), an enzyme necessary for the metabolism of triglycerides (TG). Read more...
February 1, 2016 10:15 am
Samuel Falsetti, PhD, Partner, Director of Clinical Strategy, Cambridge BioMarketing
Q&A on the challenges, approaches and best practices for discovering drugs for the rare disease market. Read more...
January 25, 2016 9:27 am
Adrian Stevens and Tim Moran, of Dassault Systèmes BIOVIA
Predictive data models and information about previous experiments can help scientists recognize which choices are likely to accelerate progress and which will lead to dead ends. The goal is to achieve better insights sooner by making data available throughout the entire workflow. Read more...
January 20, 2016 4:23 pm
Ryan Bushey, Associate Editor
The aftermath of a catastrophic clinical trial in France has raised concerns regarding the lack of data shared about the incident.  Read more...
January 19, 2016 10:00 am
Ryan Bushey, Associate Editor
Clinical research can be a risky and laborious process, but this startup could solve that problem. Read more...
January 14, 2016 8:51 am
Roger Humphrey, Executive Managing Director, JLL Life Sciences
‘Invest in the best’ sounds good in theory—but it’s becoming a costly challenge for biopharmaceutical companies expanding their R&D operations in the United States. Large, mid-sized and small companies are all facing a growing cost squeeze for labor and laboratories near leading centers for research and innovation, while efficiency continues to be a major operational driver. It’s a challenging combination. Read more...
January 12, 2016 4:22 pm
Ryan Bushey, Associate Editor
It is ill-advised to take large quantities of these vitamins over long periods of time. Read more...
January 7, 2016 12:52 pm
Ryan Bushey, Associate Editor
Current treatment strategies for vasculitis tend to involve the use of immunosuppressants like Methotrexate and Prednisone. Read more...
January 6, 2016 8:52 am
Greg Watry, Digital Reporter
Paul DePodesta, the assistant general manager for the Oakland Athletics between 1998 and 2004, is bringing his statistical prowess to Scripps Translational Science Institute. Read more...
Subscribe to Drug Discovery & Development